Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-07

Clinical Trial Update: Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing 24-hour intraocular pressure control between latanoprost and tafluprost in primary open-angle glaucoma or ocular hypertension h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)
  • Tafluprost (tafluprost)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED